Mouse Anti-PCDH1 Recombinant Antibody (2E8) (CBMAB-P0955-YC)

Ye, Z., Yang, Y., Wei, Y., Li, L., Wang, X., & Zhang, J. (2024). Correction: PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1. Cell Death & Disease, 15(1).

Du, X., Yi, X., Zou, X., Chen, Y., Tai, Y., Ren, X., & He, X. (2023). PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy. BMC cancer, 23(1), 1102.

Tellez, G. M. F. (2023). Breaking barriers: new insights into the contribution of the protocadherin-1 (PCDH1) gene in asthma.

Ye, Z., Yang, Y., Wei, Y., Li, L., Wang, X., & Zhang, J. (2022). PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1. Cell Death & Disease, 13(7), 633.

Slough, M. M., Herbert, A. S., Kuehne, A. I., Dye, J. M., Chandran, K., & Jangra, R. K. (2020, June). Mapping the Interface between New World Hantaviruses and Their Receptor, PCDH1. In Proceedings (Vol. 50, No. 1, p. 8). MDPI.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols